✨️ It's been a long time coming ✨️
https://t.co/VX330oPQC4
Really excited to finally be able to share the publication of my first first-author research paper in PLOS Biology today!
A Thread 🧵
We have 2 fully funded PhD studentships available through the new Yorkshire Biosciences DTP (starting Oct 25) - please share! Both projects are focussed on #phage that infect #Cdifficile
Happy to say I passed my PhD viva yesterday! Im so grateful for the most amazing 4 years. Special thanks to @RobFagan and Mike Brockhurst, the lab, and everyone who made the last 4 years so fantastic. Thanks also to my examiners @SmitsLab and @corrigar1 for a great viva! #PhDone
The second chapter of my PhD is out! We are bringing new elements for the potential use oof auranofin as a Clostridioides difficile treatment
https://t.co/TYr8HMP62H
#Cdifficile is mainly treated with #vancomycin, so why is resistance not yet a problem? @BuddleJess @BrockhurstLab @RobFagan &co identify 2 resistance pathways that evolve rapidly but with fitness costs that could affect transmission #AMR#PLOSBiology https://t.co/ELqtjnr2zw
Researchers @BuddleJess, @RobFagan and team have discovered how the hospital superbug C.diff rapidly evolves resistance to the frontline drug used for treatment in the UK.
Read Rob's thread to find out more about the study 👇
@RobFagan@LucyThmpsn@asw_stafford @ClaireyBaggins @RoyChaudhuri 🧵16
A final note to say (first) thanks for reading!
And (second) i am #opentowork - looking for roles in the life sciences sphere. Grateful for any reposts, connections and advice :)
✨️ It's been a long time coming ✨️
https://t.co/VX330oPQC4
Really excited to finally be able to share the publication of my first first-author research paper in PLOS Biology today!
A Thread 🧵
@RobFagan@LucyThmpsn@asw_stafford @ClaireyBaggins @RoyChaudhuri 🧵15
If you got to the end of this mammoth post and dont want to scroll back up, the paper is here 😉
https://t.co/VX330oPQC4